Published in Vaccine on September 09, 2010
A critical literature review of health economic evaluations of rotavirus vaccination. Hum Vaccin Immunother (2013) 0.94
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93
Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med (2007) 6.54
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med (2015) 4.23
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis (2012) 3.94
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infect Dis (2011) 3.04
Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J (2006) 2.83
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf (2010) 2.57
Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J (2011) 2.33
Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS (2006) 2.26
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Med (2009) 2.16
Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis (2010) 2.16
Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. J Infect Dis (2011) 2.13
Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis (2007) 1.99
Drug use in children: cohort study in three European countries. BMJ (2008) 1.91
Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population. J Infect Dis (2013) 1.64
Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. J Pediatr (2003) 1.64
Market Access Agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts. BMC Health Serv Res (2011) 1.59
Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br J Psychiatry (2007) 1.57
Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics. Pediatrics (2005) 1.55
Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J (2006) 1.54
Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS (2009) 1.49
Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry (2004) 1.44
Effects of nutritional rehabilitation on intestinal function and on CD4 cell number in children with HIV. J Pediatr Gastroenterol Nutr (2002) 1.43
Intussusception among young children in Europe. Pediatr Infect Dis J (2006) 1.42
Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect (2011) 1.40
Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr (2013) 1.29
Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART. AIDS (2007) 1.28
Impact of community-acquired paediatric rotavirus gastroenteritis on family life: data from the REVEAL study. BMC Fam Pract (2010) 1.24
Assessment of pediatric asthma drug use in three European countries; a TEDDY study. Eur J Pediatr (2010) 1.19
Burden on caregivers of people with schizophrenia: comparison between Germany and Britain. Br J Psychiatry (2007) 1.17
Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review. BMC Infect Dis (2012) 1.16
Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life. Pediatrics (2007) 1.15
Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy. BMC Infect Dis (2009) 1.14
Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS (2002) 1.14
Distribution of rotavirus genotypes in Europe, 2004-2005: the REVEAL Study. J Infect Dis (2007) 1.13
Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1. Pediatr Infect Dis J (2003) 1.13
Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response. Antivir Ther (2008) 1.13
Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study. Vaccine (2011) 1.12
A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology (2012) 1.12
Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense? Pediatr Infect Dis J (2006) 1.10
Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. Vaccine (2011) 1.10
A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J (2004) 1.10
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project. J Am Med Inform Assoc (2012) 1.09
Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines. Pediatr Infect Dis J (2009) 1.09
Intussusception after human rotavirus vaccine. Pediatr Infect Dis J (2013) 1.08
Defining off-label and unlicensed use of medicines for children: results of a Delphi survey. Pharmacol Res (2008) 1.08
Older children and adolescents surviving with vertically acquired HIV infection. J Acquir Immune Defic Syndr (2002) 1.07
Databases for pediatric medicine research in Europe--assessment and critical appraisal. Pharmacoepidemiol Drug Saf (2008) 1.07
EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. Stud Health Technol Inform (2011) 1.06
Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy. J Infect Dis (2006) 1.05
Pregnancy and HIV infection: A european consensus on management. AIDS (2002) 1.04
Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses. Pediatr Infect Dis J (2013) 1.04
Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children. J Infect Dis (2011) 1.03
Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. J Infect Dis (2009) 1.03
Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. PLoS One (2013) 1.02
Access to orphan drugs in Europe: current and future issues. Expert Rev Pharmacoecon Outcomes Res (2012) 1.01
Rotavirus types in Europe and their significance for vaccination. Pediatr Infect Dis J (2006) 1.01
A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med (2005) 1.00
IL-10 gene polymorphism at -1082 A/G is associated with severe rhinovirus bronchiolitis in infants. Pediatr Pulmonol (2008) 1.00
Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009. BMC Infect Dis (2011) 0.99
Viral etiology and incidence of acute gastroenteritis in young children attending day-care centers. Pediatr Infect Dis J (2005) 0.99
Antidepressant monotherapy: A claims database analysis of treatment changes and treatment duration. Clin Ther (2010) 0.98
Quality of life is predictive of relapse in schizophrenia. BMC Psychiatry (2013) 0.98
Clinical trials of rotavirus vaccines in Europe. Pediatr Infect Dis J (2006) 0.98
The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands. Pharmacol Res (2010) 0.98
Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1. J Transl Med (2010) 0.98
The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC). Eur Arch Psychiatry Clin Neurosci (2012) 0.97
Comparison of antiepileptic drug prescribing in children in three European countries. Epilepsia (2009) 0.97
Norovirus gastroenteritis in young children receiving human rotavirus vaccine. Scand J Infect Dis (2010) 0.97
Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents. AIDS (2008) 0.96
European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary. J Pediatr Gastroenterol Nutr (2008) 0.96
Options for the prevention of rotavirus disease other than vaccination. J Pediatr Gastroenterol Nutr (2008) 0.96
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up. Pediatr Infect Dis J (2014) 0.95
Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model. BMC Public Health (2011) 0.95
A critical literature review of health economic evaluations of rotavirus vaccination. Hum Vaccin Immunother (2013) 0.94
Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine (2009) 0.94
Factors contributing to frequent use of psychiatric inpatient services by schizophrenia patients. Soc Psychiatry Psychiatr Epidemiol (2004) 0.94
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women. AIDS (2013) 0.93
Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries. Drug Saf (2013) 0.93
Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis. Pediatr Infect Dis J (2010) 0.92
Simultaneous presence of human herpesvirus 6 and adenovirus infections in intestinal intussusception of young children. Acta Paediatr (2012) 0.92
The immunological and virological consequences of planned treatment interruptions in children with HIV infection. PLoS One (2013) 0.92
Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010. Scand J Infect Dis (2011) 0.92
The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study. Soc Psychiatry Psychiatr Epidemiol (2005) 0.92
Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children. AIDS (2012) 0.92
Residential area and social contacts in schizophrenia. Results from the European Schizophrenia Cohort (EuroSC). Soc Psychiatry Psychiatr Epidemiol (2007) 0.91
A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA). Arch Dis Child (2011) 0.91
Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen). Hum Vaccin (2011) 0.90
Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis. BMC Psychiatry (2011) 0.90
Detection of human coronaviruses in children with acute gastroenteritis. J Clin Virol (2010) 0.90
Innovative study design for paediatric clinical trials. Eur J Clin Pharmacol (2011) 0.90
Design of patient access schemes in the UK: influence of health technology assessment by the National Institute for Health and Clinical Excellence. Appl Health Econ Health Policy (2011) 0.90
Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine (2007) 0.90
Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis. Pediatr Infect Dis J (2012) 0.90
Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. J Infect Dis (2013) 0.90
Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants. AIDS (2013) 0.90
Human bocaviruses are commonly found in stools of hospitalized children without causal association to acute gastroenteritis. Eur J Pediatr (2014) 0.89
Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries. Eur J Clin Pharmacol (2012) 0.89
European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe. J Pediatr Gastroenterol Nutr (2008) 0.89